ADVA
5.5.2022 09:02:06 CEST | Business Wire | Press release
ADVA (FSE: ADV) today announced that it’s playing a key role in three research and development (R&D) projects building future-proof secure communication networks based on quantum key distribution (QKD). Funded by Germany’s Federal Ministry of Education and Research (BMBF), the initiatives aim to address the significant cybersecurity threat posed by quantum hacking and create the next generation of quantum-safe transport infrastructure with technology made in Germany. In cooperation with other consortium partners, ADVA will accelerate the commercial adoption of QKD technology by making it deployable at scale, robust and easy to integrate.
“The looming threat of large quantum computers puts our most sensitive data at risk. There’s also the immediate danger of cybercriminals harvesting encrypted information now so they can decrypt it when quantum computers become accessible. This is why the switch to quantum-safe encryption is essential for the long-term security of critical data. QKD is based on quantum technology and protects the key exchange between communication endpoints. Even if there is future progress in decryption algorithms and computational capabilities, either classical or quantum, an adversary cannot intercept the keys,” said Michael Roth, GM at Network Security, ADVA. “We understand the requirements of both the quantum and the communication world. By lending our technology and know-how, we’re bridging the gap between them. The BMBF-funded initiatives we’re involved in will make QKD usable for commercial and government customers. Together with our partners, we’re moving this technology to the next level for robust, seamless deployment at scale in today’s optical networks.”
Each of the three projects involves a consortium of industry and research partners with leading expertise in quantum technologies, cryptography, optical communication, and network operation. Coordinated by Deutsche Telekom, the DemoQuanDT project will demonstrate secure quantum key exchange over a fiber optic link between Berlin and Bonn and investigate key management in a multi-vendor environment. Led by Infosim, the QuNet+ML project will research methods for optimizing quantum key distribution in large-scale networks using machine learning. And finally, the DE-QOR project led by ADVA will develop compact and cost-effective continuous-variable QKD (CV-QKD) technology compatible with existing metro and long-distance fiber infrastructure.
“QKD offers a way to achieve true long-term network security today. In just a few years, we’re likely to see current public key cryptosystems rendered obsolete by malicious actors with quantum computers, whether that’s criminal organizations seeking profit or state-sponsored actors aiming to infiltrate critical national infrastructure. It’s therefore crucial that we harness quantum technology quickly in order to stay ahead in the cybersecurity race. Our involvement in these latest BMBF projects is testament to ADVA’s role as a leader in this vital R&D space,” commented Helmut Griesser, director of advanced technology at ADVA. “From day one, our ConnectGuard™ encryption technology has been at the forefront of quantum-safe communication by offering an open, standards-based interface to external QKD systems. Leveraging our expertise in coherent transmission, digital signal processing and cryptography, we’re now working towards our own CV-QKD solution to give customers more choice.”
About ADVA
ADVA is a company founded on innovation and focused on helping our customers succeed. Our technology forms the building blocks of a shared digital future and empowers networks across the globe. We’re continually developing breakthrough hardware and software that leads the networking industry and creates new business opportunities. It’s these open connectivity solutions that enable our customers to deliver the cloud and mobile services that are vital to today’s society and for imagining new tomorrows. Together, we’re building a truly connected and sustainable future. For more information on how we can help you, please visit us at www.adva.com
.
Published by:
ADVA Optical Networking SE, Munich, Germany
www.adva.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20220504005590/en/
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Carnegie Mellon University and Cleveland Clinic Develop AI System to Interpret Cardiac MRI Scans with Enhanced Accuracy21.5.2026 14:05:00 CEST | Press release
Trained on more than 13,000 patient studies, novel system significantly outperforms existing models by up to 35% A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s Cardiovascular Innovation Research Center, has developed an artificial intelligence (AI) system capable of interpreting some of the most complex heart scans in medicine, cardiac magnetic resonance imaging (MRI), without the need for manually labeled training data. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521762286/en/ A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s Cardiovascular Innovation Research Center, has developed an artificial intelligence (AI) system capable of interpreting some of the most complex heart scans in medicine, cardiac magnetic resonance imaging (MRI), without the need for manually labeled training data. The novel system, called CMR-CLIP, is d
Otovo Hits 30,000 Customers in Under a Year, Tackling the Growing ‘Solar Service Crisis’21.5.2026 14:00:00 CEST | Press release
A growing wave of unsupported solar systems and rising electricity prices are creating strong demand for Otovo’s energy service platform Otovo ASA (“Otovo”), a leading global energy service provider for residential and commercial customers, today announced it has reached 30,000 customers across the U.S. and Europe. A total of 20,000 customers have enrolled in Otovo Care, the Company’s membership-based home and commercial energy service, which is powered by Otovo’s industry-leading AI platform, Endurance™. “Reaching 30,000 customers in less than year is proof positive that home and business owners value their power systems,” said William J. (John) Berger, CEO of Otovo. “The ‘solar service crisis’ that is leaving millions of orphaned energy systems without support is driving strong interest in our Otovo Care membership program. Every day your home or commercial power system is not working, you are throwing money away. Otovo’s rapid response service platform keeps you up and running, ensu
The Live Moment Effect: Genius Sports and MediaScience Study Finds Specific Moments in Live Sports Can Double Unaided Brand Recall21.5.2026 14:00:00 CEST | Press release
New research shows that brands aligned with emotionally heightened moments in live sports can improve ad effectiveness Genius Sports Limited (NYSE: GENI), a global leader in real-time sports data, today released new biometric research conducted with MediaScience showing that ads delivered immediately after emotionally heightened moments in live sports can double unaided brand recall. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521475265/en/ The Live Moment Effect report from Genius Sports and MediaScience. The study, The Live Moment Effect, finds that advertising effectiveness is significantly influenced by a viewer’s emotional state immediately before an ad is shown. In controlled biometric testing, ads shown after high-intensity sporting moments, such as near-scoring plays or crucial momentum shifts, delivered approximately double the unaided brand recall of baseline conditions. The Moment Before the Ad Matters The r
Merck Announces First Patient Dosed in Phase 3 Study for Investigational Antibody-Drug Conjugate in Colorectal Cancer21.5.2026 14:00:00 CEST | Press release
Precemtabart tocentecan (Precem-TcT) is investigated as a potential first-in-class anti-CEACAM5 ADC, for the treatment of metastatic CRC (mCRC) CEACAM5 is overexpressed in the majority of colorectal tumors (~90%), and requires no patient selection Significant unmet need remains for clinically meaningful innovation in colorectal cancer (CRC), the second leading cause of cancer death worldwide Not intended for Canada-, UK- or US-based media Merck, a leading science and technology company, today announced that the first patient has been dosed in the Phase 3 PROCEADE®-CRC-03 trial (NCT07549412). The study is evaluating precemtabart tocentecan (Precem‑TcT), a potential first‑in‑class investigational anti‑CEACAM5 antibody‑drug conjugate (ADC), for the treatment of metastatic colorectal cancer (mCRC). “Leveraging our novel payload‑linker technology, Precem‑TcT is the first CEACAM5‑targeted ADC in clinical studies with an exatecan payload, rationally designed for stability and enhanced cancer
Baszucki Group Funds Oxford University Clinical Trial of Ketogenic Therapy for Early Psychosis21.5.2026 13:00:00 CEST | Press release
Randomized controlled trial will evaluate both symptom progression and underlying biology Baszucki Group today announced a £1.17 million grant to support a randomized controlled trial at the University of Oxford assessing the feasibility, safety, and efficacy of a ketogenic diet for patients at clinical high risk of psychosis (CHR-P). Researchers will test this nutritional therapy's ability to improve patients' mental and physical health. This project builds on a growing body of research suggesting the potential of metabolic therapies in treating serious mental illness. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521877110/en/ Baszucki Group Funds £1.17 Million for University of Oxford Trial of Ketogenic Therapy for Early Psychosis Psychotic disorders carry a massive personal burden and are associated with a lower life expectancy. Psychosis does not develop immediately, but typically emerges following a period of early
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
